Siemens Healthineers : FY due 4 Nov - FY to beat, remaining an attractive growth story
>Expecting a FY beat on adjusted EPS - Looking at Q4, we forecast a strong quarter again with comparable sales growth of 11.6% y-o-y. While this would not be as strong as in Q1, Q2 or in Q3, it mainly reflects that SARS-CoV-2 antigen test sales will only be at an estimated € 80m in Q4 (volume, price pressure), the lowest level in 2021. This would be in-line with guidance (no point of concern). Besides we estimate a solid performance for all segments (Imaging +9% y-o-y...Siemens Healthineers AG is a Germany-based company that supplies technology to the healthcare industry. The Company offers a wide range of products and services in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine. It provides medical technology and software solutions, as well as clinical consulting services. Additionally, the Company is developing its digital health and enterprise services trough expanding precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare to enable healthcare providers to increase value. Siemens AG is a majority shareholder of the Company. The Company is active worldwide.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.